Interestingly, there may be a synergistic effect between HER2 inhibition and CPIs since trastuzumab has been found to upregulate PD-1 and PD-L1 expression and increase tumour-infiltration lymphocytes [52]. The gene discussed is CD274; the disease is neoplasm.